NCT01984606View on ClinicalTrials.gov

Efficacy and Safety of Empagliflozin Versus Sitagliptin in Patients With Type 2 Diabetes

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Empagliflozin

Empagliflozin once daily

DRUG

Placebo

Placebo matching empagliflozin

DRUG

Sitagliptin

Sitagliptin once daily

DRUG

Placebo

Placebo matching sitagliptin

Sponsors
All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY